NCT00262938 arm group ae5baad29f8bca7452d79a417243f23f [clinicaltrials_resource:NCT00262938/arm-group/ae5baad29f8bca7452d79a417243f23f]
NCT00262938 arm group ae5baad29f8bca7452d79a417243f23f [clinicaltrials_resource:NCT00262938/arm-group/ae5baad29f8bca7452d79a417243f23f]
Bio2RDF identifier
NCT00262938/arm-group/ae5baad29f8bca7452d79a417243f23f
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 5baad29f8bca7452d79a417243f23f
description [clinicaltrials_vocabulary:description]
Patients undergo quality of li ...... ne and at 3, 6, and 12 months.
identifier
clinicaltrials_resource:NCT00262938/arm-group/ae5baad29f8bca7452d79a417243f23f
title
NCT00262938 arm group ae5baad29f8bca7452d79a417243f23f
@en
type
label
NCT00262938 arm group ae5baad2 ...... baad29f8bca7452d79a417243f23f]
@en